BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28884749)

  • 1. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
    Lavigne M; Menet E; Tille JC; Lae M; Fuhrmann L; Bonneau C; Deniziaut G; Melaabi S; Ng CCK; Marchiò C; Rouzier R; Bièche I; Vincent-Salomon A
    Mod Pathol; 2018 Jan; 31(1):68-82. PubMed ID: 28884749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
    Basturk O; Tang L; Hruban RH; Adsay V; Yang Z; Krasinskas AM; Vakiani E; La Rosa S; Jang KT; Frankel WL; Liu X; Zhang L; Giordano TJ; Bellizzi AM; Chen JH; Shi C; Allen P; Reidy DL; Wolfgang CL; Saka B; Rezaee N; Deshpande V; Klimstra DS
    Am J Surg Pathol; 2014 Apr; 38(4):437-47. PubMed ID: 24503751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
    Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
    Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
    Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
    Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
    Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
    Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
    Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
    Akintola-Ogunremi O; Pfeifer JD; Tan BR; Yan Y; Zhu X; Hart J; Goldblum JR; Burgart L; Lauwers GY; Montgomery E; Lewin D; Washington K; Bronner M; Xiao SY; Greenson JK; Lamps L; Lazenby A; Wang HL
    Am J Surg Pathol; 2003 Dec; 27(12):1551-8. PubMed ID: 14657715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets.
    Ang D; Ballard M; Beadling C; Warrick A; Schilling A; O'Gara R; Pukay M; Neff TL; West RB; Corless CL; Troxell ML
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):97-103. PubMed ID: 25679062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas.
    Jesinghaus M; Konukiewitz B; Keller G; Kloor M; Steiger K; Reiche M; Penzel R; Endris V; Arsenic R; Hermann G; Stenzinger A; Weichert W; Pfarr N; Klöppel G
    Mod Pathol; 2017 Apr; 30(4):610-619. PubMed ID: 28059096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
    Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM
    Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.
    Shafi S; Hu Y; Parwani AV; Ding Q; Li Z
    Breast Cancer Res Treat; 2022 Dec; 196(3):463-469. PubMed ID: 36260193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
    Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
    Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
    Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
    Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.